1Bleeker WK,Teeling JL,Erik Hack C.Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect.Blood,2001,98: 3136-3142.
2Hundt M,Manger K,Dorner T,et al.Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin.Rheumatology,2000,39: 1301-1302.
3Emmi L,Chiarini F.The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.Neurol Sci,2002,23 (Suppl) 1 :S 1-8.
4Jordan SC,Tyan D,Czer L,et al.Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ transplant recipients.Pediatr Transplant,1998,2:92-105.
5Sewell WAC,Jolles S.Immunomodulatory action of intravenous immunoglobulin.Immunology,2002,107:387.
6Bayry J,Lacroix-Desmazes S,Carbonneil C,et al.Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin.Blood,2003,101: 758-765.
7Yu Z,Lennon VA.Mechanism of Intravenous Immune Globulin Therapy in Antibody-Mediated Autoimmune Diseases.New Engl J Med,1999,340:227-228.
9Marinos C,Dalakas MD.Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies.Neurology,2002,59:S13-S21.
10Genevay S,Saudan-Kister A,Guerne PA.Intravenous gammaglobulins in refractory polymyositis: lower dose for maintenance treatment is effective.Ann Rheum Dis,2001,60:635-636.
